The evidence-based updates, which reflect major advances in disease management, include: Clopidogrel -- A combination of aspirin and the oral antiplatelet drug clopidogrel might be considered to prevent stroke or other types of blood clots in atrial fibrillation patients who are poor candidates for the clot-preventing drug warfarin.